FOX RUN MANAGEMENT, L.L.C.

Position in RPRX — Royalty Pharma plc

CIK 1533457 GREENWICH, CT

Position in RPRX

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$1,350,950

+$453,192 QoQ

Shares Held

24,094

+28.7% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

#301

of 644 holders

Holding Since

Sep 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FOX RUN MANAGEMENT, L.L.C. holds $29,784,980 across 59 Biotechnology names. RPRX ranks #2 (4.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NAMS	NewAmsterdam Pharma Co N.V.	59,477	$2,015,675
2	RPRX	Royalty Pharma plc This page	24,094	$1,350,950
3	IMVT	Immunovant, Inc.	34,827	$1,341,884
4	ASND	Ascendis Pharma A/S	4,726	$1,260,518
5	VKTX	Viking Therapeutics, Inc.	28,315	$1,104,568
6	ARQT	Arcutis Biotherapeutics, Inc.	38,178	$1,001,027
7	EXEL	Exelixis, Inc.	18,255	$993,254
8	EYPT	EyePoint, Inc.	58,528	$836,950

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,350,950	24,094	+28.7%	Shares	Sole	2026-08-04
2026-03-31	$897,758	18,715	-9.4%	Shares	Sole	2026-05-12
2025-03-31	$642,709	20,646	-62.5%	Shares	Sole	2025-05-13
2024-12-31	$1,404,631	55,062	+41.3%	Shares	Sole	2025-02-11
2024-09-30	$1,102,687	38,978	+3.7%	Shares	Sole	2024-11-12
2024-06-30	$991,380	37,595	+49.9%	Shares	Sole	2024-08-13
2024-03-31	$761,892	25,087	+223.7%	Shares	Sole	2024-05-13
2023-06-30	$238,235	7,750	-67.0%	Shares	Sole	2023-08-11
2023-03-31	$845,011	23,453	+146.0%	Shares	Sole	2023-05-12
2022-12-31	$376,783	9,534	-35.5%	Shares	Sole	2023-02-07
2022-03-31	$576,101	14,787	+70.8%	Shares	Sole	2022-05-10
2021-09-30	$312,936	8,659	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.